Targeted Imaging of Melanoma for Alpha-Particle Radiotherapy

NCT04904120 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma (Skin)
Melanoma Stage IV
Melanoma, Uveal
Melanoma, Mucosal

Interventions

DRUG: [203Pb]VMT01
DRUG: [68Ga]VMT02

Sponsor

Perspective Therapeutics

Collaborators

[object Object]